Allergy Therapeutics Working Capital to Net Assets Ratio
Allergy Therapeutics working capital to net assets ratio. Allergy Therapeutics (AGY) has a Working Capital to Net Assets ratio of 99.4% as of December 2025. Working capital of GBX4.22 Million (current assets of GBX36.25 Million minus current liabilities of GBX32.03 Million) is measured against net assets of GBX4.25 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check AGY intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Allergy Therapeutics (2002–2025)
Working capital to net assets ratio of Allergy Therapeutics from 2002 to 2025. This chart shows how Allergy Therapeutics's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 99.4%, reflecting working capital of GBX4.22 Million against net assets of GBX4.25 Million GBX. See AGY defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Allergy Therapeutics Working Capital to Net Assets Ratio by Year (2002–2025)
Allergy Therapeutics working capital to net assets ratio by year from 2002 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Allergy Therapeutics from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Allergy Therapeutics balance sheet assets.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -26.5% | GBX7.49 Million | GBX-28.19 Million | GBX34.68 Million | GBX27.19 Million | ▼ -375.3 pp |
| 2024 | 348.8% | GBX12.94 Million | GBX3.71 Million | GBX33.48 Million | GBX20.55 Million | ▼ -375.4 pp |
| 2023 | 724.2% | GBX14.96 Million | GBX2.07 Million | GBX33.53 Million | GBX18.57 Million | ▲ +659.7 pp |
| 2022 | 64.5% | GBX24.34 Million | GBX37.77 Million | GBX42.39 Million | GBX18.05 Million | ▼ -17.2 pp |
| 2021 | 81.6% | GBX39.63 Million | GBX48.53 Million | GBX57.86 Million | GBX18.23 Million | ▼ -2.7 pp |
| 2020 | 84.4% | GBX36.94 Million | GBX43.78 Million | GBX55.17 Million | GBX18.23 Million | ▲ +5.1 pp |
| 2019 | 79.3% | GBX29.77 Million | GBX37.56 Million | GBX46.62 Million | GBX16.86 Million | ▲ +8.5 pp |
| 2018 | 70.8% | GBX16.30 Million | GBX23.03 Million | GBX30.93 Million | GBX14.63 Million | ▼ -7.5 pp |
| 2017 | 78.2% | GBX23.44 Million | GBX29.96 Million | GBX37.46 Million | GBX14.02 Million | ▼ -4.5 pp |
| 2016 | 82.7% | GBX25.09 Million | GBX30.32 Million | GBX37.61 Million | GBX12.52 Million | ▲ +6.2 pp |
| 2015 | 76.5% | GBX26.37 Million | GBX34.47 Million | GBX33.79 Million | GBX7.42 Million | ▲ +25.2 pp |
| 2014 | 51.3% | GBX7.74 Million | GBX15.07 Million | GBX14.21 Million | GBX6.47 Million | ▲ +4.7 pp |
| 2013 | 46.6% | GBX6.84 Million | GBX14.67 Million | GBX14.46 Million | GBX7.62 Million | ▲ +10.4 pp |
| 2012 | 36.2% | GBX5.29 Million | GBX14.59 Million | GBX13.03 Million | GBX7.75 Million | ▼ -139.9 pp |
| 2011 | 176.1% | GBX3.77 Million | GBX2.14 Million | GBX14.91 Million | GBX11.15 Million | ▲ +52.1 pp |
| 2010 | 124.0% | GBX4.82 Million | GBX3.89 Million | GBX14.80 Million | GBX9.98 Million | ▲ +70.8 pp |
| 2009 | 53.2% | GBX-12.33 Million | GBX-23.18 Million | GBX9.44 Million | GBX21.77 Million | ▲ +81.7 pp |
| 2008 | -28.4% | GBX3.21 Million | GBX-11.29 Million | GBX11.32 Million | GBX8.11 Million | ▼ -65.4 pp |
| 2007 | 37.0% | GBX3.18 Million | GBX8.60 Million | GBX14.04 Million | GBX10.86 Million | ▼ -43.0 pp |
| 2006 | 80.0% | GBX26.15 Million | GBX32.70 Million | GBX31.09 Million | GBX4.94 Million | ▲ +6.0 pp |
| 2005 | 74.0% | GBX14.86 Million | GBX20.08 Million | GBX20.98 Million | GBX6.12 Million | ▲ +41.6 pp |
| 2004 | 32.4% | GBX2.29 Million | GBX7.08 Million | GBX5.57 Million | GBX3.28 Million | ▲ +5.3 pp |
| 2003 | 27.0% | GBX1.50 Million | GBX5.55 Million | GBX5.50 Million | GBX4.00 Million | ▲ +3.9 pp |
| 2002 | 23.1% | GBX-1.02 Million | GBX-4.40 Million | GBX3.58 Million | GBX4.59 Million | — |